dc.creatorKonttinen, Y.
dc.creatorAzuma, M.
dc.creatorGonzález Burgos, M.
dc.creatorCovarrubias, S.
dc.creatorCastillo, C.
dc.creatorCampos, L.
dc.date.accessioned2021-06-02T04:49:19Z
dc.date.accessioned2024-05-02T15:05:10Z
dc.date.available2021-06-02T04:49:19Z
dc.date.available2024-05-02T15:05:10Z
dc.date.created2021-06-02T04:49:19Z
dc.date.issued2004-07
dc.identifierArthritis and Rheumatism, Volume 50, Issue 7, July 2004, Page 2374
dc.identifier0004-3591
dc.identifierhttp://repositorio.unab.cl/xmlui/handle/ria/18997
dc.identifierDOI: 10.1002/art.20307
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9262166
dc.languageen
dc.publisherJohn Wiley and Sons Inc.
dc.subjectSjoegren Syndrome
dc.subjectMinor Saliva Gland
dc.subjectXerophthalmia
dc.subjectgelatinase B
dc.subjectcell ultrastructure
dc.titleMatrix metalloproteinase 9 in the saliva of patients with Sjögren's syndrome: Comment on the article by Goicovich et al [2] (multiple letters)
dc.typeArtículo


Este ítem pertenece a la siguiente institución